Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News Padcev and Keytruda combo cuts bladder cancer recurrence risk by 60% in pivotal Phase 3 win Discover how the Padcev and Keytruda combination achieved unprecedented survival gains in bladder cancer — read our expert take. bySrinathOctober 19, 2025